期刊文献+

p53与人类肺癌关系研究的进展 被引量:13

原文传递
导出
摘要 p53基因是目前人类所发现的与肿瘤发病相关性最大的抑癌基因(tumorsuppressorgene,TSG)。p53基因的点突变、缺失及灭活在肺癌的发生和进展过程中起着关键性的作用。随着各项研究的不断进展以及高新检测技术的出现,p53在肺癌的早期诊断中的价值得到进一步的肯定。同时,利用p53进行基因治疗及评价肺癌患者预后的研究也逐渐开展起来并取得一定成效。因此深入探讨p53基因与人类肺癌的关系具有重大的意义。本文就p53与人类肺癌关系研究的进展作一论述。
作者 吴忧 白澎
出处 《国际呼吸杂志》 2006年第2期99-102,共4页 International Journal of Respiration
关键词 P53 肺癌 基因治疗
  • 相关文献

参考文献34

  • 1Jonathan C, Daniel W, Roy S, Gene Therapy of Lung Cancer.Semin Surg Oncol,2003.21(3), 196-204.
  • 2Takahashi T,Carbone D,Takahashi T,et al. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res, 1992,52(8) : 2340-2343.
  • 3Mechanic LE, Marrogi AJ, Welsh JA, et al. Polymorphisms in XPD and Tp53 and mutation in human lung cancer.Carcinogenesis, 2005,26(3) :597-604.
  • 4Park JK,Lee HJ,Kim JW,et a1.Differences in p53 gene polymorphisms between korean schizophrenia and lung cancer patients.Schizophr Res,2004,67(1):71-74.
  • 5Mahasneh AA,Abdel-Hafiz.SS.Polymorphism of p53 gene in jordanian population and possible associations with breast cancer and lung adenocarcinoma.Saudi Med J,2004,25(11):1568—1573.
  • 6李琰 ,张健慧 ,王瑞 ,段丽红 ,郭炜 ,温登瑰 ,魏丽珍 .p53^(PIN3)基因多态性与食管癌及肺癌发病风险关系的研究[J].肿瘤,2004,24(2):146-148. 被引量:8
  • 7Tockman MS. Clinical Detection of lung cancer progression markers, J Cell Biochem,1996, 25 (Suppl) : 177-184.
  • 8Keohavong P,Gao WM,Zheng KC,et al. Detection of k-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdisseetion microscope and mutation analysis,Anal Biochem,2004,324(1) :92-99.
  • 9Keohavong P,Lan Q,Gao WM,et al. Detection of p53 and k-ras mutations in sputum of individuals exposed to smoky coal emissions in Xuan Wei county, China. Carcinogenesis, 2005,26(2) ;303-308.
  • 10汪斌超,李龙芸,程书钧,高燕宁.变性高压液相色谱法分析肺癌患者痰标本Rb2/p130、p53基因突变[J].中华内科杂志,2004,43(7):499-501. 被引量:2

二级参考文献44

  • 1李蓉,李睿.肺癌肿瘤标记物研究进展[J].国外医学(肿瘤学分册),1996,23(2):98-103. 被引量:29
  • 2Mountain CF.Revisions in the international system for staging of lung cancer [J].Chest,1997,111(7):1710-1717.
  • 3Szymanska K,Hainaut P.TP53 and mutations in human cancer [J].Acta Biochim Pol,2003,50(1):231-238.
  • 4Hainaut P,Hollstein M.p53 and human cancer:the first ten thousand mutations [J].Adv Cancer Res,2000,77:81-137.
  • 5Dowlatshahi K,Fan M,Bloom KJ,et al.Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma [J].Cancer,1999,86(6):990-996.
  • 6Ghossein RA,Rosai J.Polymerase chain reaction in the detection of micrometastases and circulating tumor cells [J].Cancer,1996,78(1):10-16.
  • 7Castaldo G,Tomaiuolo R,Sanduzzi A,et al.Lung cancer metastatic cells detected in blood by reverse transcriptase-polymerase chain reaction and dot blot analysis [J].J Clin Oncol,1997,15(11):3388-3393.
  • 8Ferrari AC,Stone NN,Eyler JN,et al.Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high risk prostate cancer [J].J Natl Cancer Inst,1997,89(20):1498-1504.
  • 9Fisher ER,Swamidoss S,Lee CH,et al.Detection and significance of occult axillary node metastases in patients with invasive breast cancer [J].Cancer,1978,42(4):2025-2031.
  • 10Komukai S,Nishimaki T,Suzuki T,et al.Significance of immunohistochemical nodal micrometastasis as a prognostic indicator in potentially curable oesophageal carcinoma [J].Br J Surg,2002,89(2):213-219.

共引文献25

同被引文献173

引证文献13

二级引证文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部